VCG
Vantage Consulting Group’s Gilead Sciences GILD Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-3,577
| Closed | -$245K | – | 70 |
|
|
2024
Q2 | $245K | Buy |
3,577
+415
| +13% | +$28.5K | 0.18% | 100 |
|
|
2024
Q1 | $232K | Buy |
3,162
+198
| +7% | +$14.5K | 0.15% | 154 |
|
|
2023
Q4 | $240K | Sell |
2,964
-86
| -3% | -$6.97K | 0.16% | 142 |
|
|
2023
Q3 | $229K | Buy |
3,050
+108
| +4% | +$8.09K | 0.15% | 145 |
|
|
2023
Q2 | $227K | Sell |
2,942
-69
| -2% | -$5.32K | 0.13% | 174 |
|
|
2023
Q1 | $250K | Buy |
3,011
+265
| +10% | +$22K | 0.14% | 157 |
|
|
2022
Q4 | $236K | Sell |
2,746
-1,193
| -30% | -$102K | 0.14% | 149 |
|
|
2022
Q3 | $243K | Sell |
3,939
-22
| -0.6% | -$1.36K | 0.14% | 130 |
|
|
2022
Q2 | $245K | Buy |
3,961
+4
| +0.1% | +$247 | 0.14% | 136 |
|
|
2022
Q1 | $235K | Buy |
3,957
+259
| +7% | +$15.4K | 0.09% | 170 |
|
|
2021
Q4 | $269K | Buy |
3,698
+265
| +8% | +$19.3K | 0.07% | 157 |
|
|
2021
Q3 | $240K | Buy |
3,433
+133
| +4% | +$9.3K | 0.05% | 148 |
|
|
2021
Q2 | $227K | Buy |
+3,300
| New | +$227K | 0.04% | 172 |
|
|
2021
Q1 | – | Sell |
-1,199
| Closed | -$70K | – | 676 |
|
|
2020
Q4 | $70K | Buy |
+1,199
| New | +$70K | 0.01% | 315 |
|